早绝经年龄对绝经后类风湿关节炎女性疾病结局的影响:韩国类风湿关节炎患者大型观察性队列研究
该研究纳入2878例绝经后类风湿关节炎女性,比较早绝经(<45岁,n=437)与 usual绝经(≥45岁,n=2441)患者的临床结局。早绝经组基线疾病活动度和患者报告结局更差,且纵向5年随访中SDAI变化率、HAQ-DI评分升高及EQ-5D效用值降低均与早绝经显著相关。
要点
- 早绝经组基线疾病活动度更高、疲劳和睡眠障碍等患者报告结局更差。
- 调整年龄、病程、生物制剂使用和基线SDAI后,早绝经显著影响SDAI变化率(β=1.265,p=0.004)。
- 早绝经与5年随访期间HAQ-DI评分增加和EQ-5D效用值降低显著相关。
核心结论
- 早绝经的类风湿关节炎患者疾病活动度更高、健康相关生活质量更差。
- 早绝经显著影响类风湿关节炎患者疾病活动度和患者报告结局的纵向变化。
研究设计与样本
- 韩国关节炎观察性研究网络招募的2878例绝经后类风湿关节炎女性。
- 早绝经组(<45岁)437例,usual绝经组(≥45岁)2441例。
- 基线及连续5年使用简化疾病活动指数(SDAI)、健康评估问卷-残疾指数(HAQ-DI)和其他患者报告结局评估。
- 对基线SDAI>11的患者进行广义估计方程(GEE)分析。
主要发现
- 早绝经组较usual绝经组更年轻,但两组类风湿关节炎病程相似。
- 早绝经组受教育程度更高,入组时血清阴性比例更高。
- 早绝经组基线疾病活动度更高,总体评估、疲劳、睡眠障碍和健康相关生活质量更差(均p<0.05)。
- GEE模型显示,调整年龄、类风湿关节炎病程、生物制剂使用和基线SDAI后,早绝经显著影响SDAI变化率(β=1.265,p=0.004)。
- 5年随访期间,早绝经组与HAQ-DI评分增加和EQ-5D效用值降低显著相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the differences in clinical outcomes between patients with rheumatoid arthritis (RA) with early menopause (EM) (<45 years) and usual menopause (UM) (≥45 years) and to identify the impact of EM on longitudinal changes in RA activity and patient-reported outcomes (PROs). METHODS: We recruited 2878 postmenopausal women with RA from the Korean Observational Study Network for Arthritis. Patients were examined at baseline and for 5 consecutive years using the Simplified Disease Activity Index (SDAI), Health Assessment Questionnaire-Disability Index (HAQ-DI) and other PROs. Generalised estimating equation (GEE) analyses were performed among patients with a baseline SDAI of >11 to evaluate the impact of EM on longitudinal changes in RA activity and PROs. RESULTS: The EM group (n=437) was younger than the UM group (n=2441), but the RA duration was similar between the two groups. The EM group was more educated and more likely to be seronegative at enrolment. Moreover, the EM group demonstrated higher disease activity and worse PROs for global assessment, fatigue, sleep disturbance and health-related quality of life (HRQoL) (all p<0.05) at baseline. The GEE model revealed that EM significantly influenced the rate of SDAI change (β=1.265, p=0.004) after adjusting for age, RA duration, biologics use and SDAI at baseline. The EM group was also significantly associated with increased HAQ-DI scores and decreased EQ-5D-utility values during the 5-year follow-up period. CONCLUSION: Patients with RA and EM demonstrate higher disease activity and poorer HRQoL. Furthermore, EM significantly affects the longitudinal changes in disease activity and PROs in patients with RA.
引用
- Park EH, Kang EH, Lee YJ, et al. Impact of early age at menopause on disease outcomes in postmenopausal women with rheumatoid arthritis: a large observational cohort study of Korean patients with rheumatoid arthritis. RMD Open. 2023. PMID: 36792311. doi:10.1136/rmdopen-2022-002722
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。